Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972824 · ClinicalTrials.gov registry record
Food Survey, Curbside, Remote APPS - Laboratory
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT05972824: Completed study, sponsored by Pennington Biomedical Research Center.
NCT05972824 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05972824 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Participants will perform the FoodImage app in the lab. A survey will be provided after the study visit. Also the bag of combined waste will be given to a hired contractor who will sort and weigh the waste, thus creating a second estimate of waste and its key components using standard industry practices (i.e. curbside).
Primary Outcome
Weight (g)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2024-11-21 |
What the finished NCT05972824 record still lists
NCT05972824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05972824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05972824 about?
NCT05972824 is a clinical study titled "Food Survey, Curbside, Remote APPS - Laboratory". Participants will perform the FoodImage app in the lab. A survey will be provided after the study visit. Also the bag of combined waste will be given to a hired contractor who will sort and weigh the waste, thus creating a second estimate of waste and its key components using standard industry pract...
What is the current status of trial NCT05972824?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2023-12-13. Estimated completion is 2024-11-21.
Who is sponsoring clinical trial NCT05972824?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI